comparing glp-1 agonists Frontiers GLP-1R Agonists for Weight Loss

As per the data from the University of California Health Data Warehouse, Ozempic (semaglutide, a GLP-1 RA) users have increased from 569 to 7667 to 22,891 in 2019, 2020, and 2022, respectively [5]

Weight loss goals should be personalized to each patient and weighed against risks of contributing to sarcopenia

O'Neil PM, Birkenfeld AL, McGowan B, Mosenzon O, Pedersen SD, Wharton S, et al

In our setting, neither liraglutide nor semaglutide were available options

It targets GLP-1, GIP, and glucagon receptors simultaneously, adding a third mechanism that directly increases energy expenditure and fat oxidation through the liver

The cells were visualized through a custom-built TIRF microscope equipped with an EM-CCD camera, a 100oil-immersion objective (Nikon), high NA (NA = 1.49), and 450-nm diode laser